Eris Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Promoter Kaushal K. Shah has submitted the annual declaration confirming the promoter and promoter group collectively hold 7,47,08,744 equity shares, representing approximately 53.92% of the total equity capital of Eris Lifesciences Limited as on March 31, 2026. The disclosure is made under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing also confirms that no encumbrances (pledging or creating charges on shares) have been created during the financial year, other than those already disclosed earlier.
Promoters maintaining over 53% stake with no additional encumbrances signals stability in the promoter group's holding, which is reassuring for minority shareholders as it reduces risk of forced selling or dilution.